What's in Pharma Two B Ltd.'s pipeline?

Pharma Two B Ltd. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Pharma Two B Ltd.'s portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Kowa Company, Ltd., St. Luke's-Roosevelt Hospital Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/pharma-two-b-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Pharma Two B Ltd. — Portfolio Competitive Intelligence Brief

Pharma Two B Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Marketed Pramipexole ER	Marketed Pramipexole ER	phase 3	Dopamine D2/D3 receptor agonist	Dopamine D2 receptor, Dopamine D3 receptor	Neurology

Therapeutic area mix

Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 1 shared drug class
Kowa Company, Ltd. · 1 shared drug class
St. Luke's-Roosevelt Hospital Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Pharma Two B Ltd.:

Cite this brief

Drug Landscape (2026). Pharma Two B Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/pharma-two-b-ltd. Accessed 2026-05-15.